The issue of mortality in schizophrenia;L'enjeu de la mortalité dans la schizophrénie

Therapie

Volumn 63, Issue 3, 2008, Pages 247-250

  Corruble, Emmanuelle ^a  

^a UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

Antipsychotics; Cardio vascular disorders; Mortality; Schizophrenia; Suicide

Indexed keywords

CLOZAPINE; NEUROLEPTIC AGENT; OLANZAPINE;

CARDIOVASCULAR EFFECT; CARDIOVASCULAR RISK; DRUG EFFICACY; DRUG SAFETY; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; METABOLIC SYNDROME X; MORTALITY; OBESITY; PRIORITY JOURNAL; QT PROLONGATION; REVIEW; SCHIZOPHRENIA; SUDDEN DEAFNESS; SUICIDE; TORSADE DES POINTES; CARDIOVASCULAR DISEASE; PSYCHOLOGY; STATISTICS;

CARDIOVASCULAR DISEASES; HUMANS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SUICIDE;

EID: 54449086321     PISSN: 00405957     EISSN: None     Source Type: Journal    
DOI: 10.2515/therapie:2008029     Document Type: Article

References (12)

1. Palmer BA, Pankratz VS, Bostwick JM. The lifetime risk of suicide in schizophrenia: a reexamination. Arch Gen Psychiatry 2005; 62: 247-53
2. Meltzer HY, Alphs L, Green AI, et al. Clozapine treatment for suicidality in schizophrenia: international suicide prevention trial (InterSePT). Arch Gen Psychiatry 2003; 60: 82-91
3. Brown S. Excess mortality of schizophrenia. A meta-analysis. Br J Psychiatry 1997; 171: 502-8
4. Saha S, Chant D, McGrath J. A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? Arch Gen Psychiatry 2007; 64(10): 1123-31
5. Alberti KGMM, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus ans its complications: part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetes Med 1998; 15: 539-53
6. Ryan MC, Collins P, Thakore JH. Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia. Am J Psychiatry 2003; 160(2): 284-9
7. Thakore JH. Metabolic disturbance in first-episode schizophrenia. Br J Psychiatry Suppl 2004; 47: S76-S79
8. Ray WA, Meredith S, Thapa PB, et al. Antipsychotics and the risk of sudden death. Arch Gen Psychiatry 2001; 58: 1161-7
9. Glassman AH. Schizophrenia, antipsychotic drugs and cardiovascular disease. J Clin Psychiatry 2005; 66(S6): 5-10
10. Haddad PM, Anderson IM. Antipsychotic-related QTc prolongation, torsade de pointes and sudden death. Drugs 2002; 62(11): 1649-71
11. Corruble E. Effets cardio-vasculaires des antipsychotiques. Encéphale 2007; 33(S1): S27-30.
12. Vieweg WV. Mechanisms and risks of electrocardiograntipsychotiqueshic QT interval prolongation when using antipsychotic drugs. J Clin Psychiatry 2002; 63 (Suppl 9): 18-24